A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors – and successfully eliminated 50% of the tumors in model animals.

CRISPR Therapeutics and its partner Vertex Pharmaceuticals have the only approved CRISPR therapy. Several other biotech companies have CRISPR therapies in clinical testing. Key findings are ...

CRISPR gene editing targeted the SOX2 gene, eliminating 50% of tumors in mice. The therapy used lipid nanoparticles to deliver CRISPR directly into tumors. The study suggests CRISPR could be effective ...

2 CRISPR Cas9: Gene Therapy Play The rigid, distorted red blood cells cause all the symptoms of sickle cell disease by obstructing blood vessels, inhibiting blood flow, and causing severe pain in ...

Suffering on such an immense scale can appear hopeless. However, a technique called CRISPR gene editing promises to help deal with these issues and many more—and wise regulation can spur it on.

AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP ...

CRISPR technology is now an indispensable tool in human, animal and agricultural research. Furthermore, the FDA’s approval of a CRISPR therapy for sickle cell disease marked the beginning of a new era ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.

But if this therapy works, it will heal the muscle ... To fix the dysferlin mutation, Escobar uses CRISPR-Cas9, which is often described as "gene-editing scissors" and for which a Nobel Prize ...